Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132-Reference-Cited by-同舟云学术

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

Published:2011-12-28 Issue:4 Volume:19 Page:1074-1080
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Wang Dian,Zhang Qiang,Blanke Charles D.,Demetri George D.,Heinrich Michael C.,Watson James C.,Hoffman John P.,Okuno Scott,Kane John M.,von Mehren Margaret,Eisenberg Burton L.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-011-2190-5.pdf

Reference31 articles.

1. Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Network. 2010;8:S1–41.

2. Casali PG, Jost L, Reichardt P, et al. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Suppl 4):64–7.

3. Corless CL, Heinrich MC. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol. 2008;3:557–86.

4. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–65.

5. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708–10.

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of neoadjuvant therapy for localized gastric gastrointestinal stromal tumors and the association with survival;Journal of Gastrointestinal Surgery;2024-09

2. Pathological Complete Response After Neoadjuvant Imatinib in a Recurrent Duodenal Gastrointestinal Stromal Tumor (GIST);Cureus;2024-07-16

3. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study;Acta Oncologica;2024-05-07

4. MOLECULAR PATHWAYS AND THERAPEUTIC STRATEGIES IN DERMATOFIBROSARCOMA PROTUBERANS (DFSP): UNRAVELLING THE TUMOR'S GENETIC LANDSCAPE;EXCLI J;2024

5. Surgical management of a locally advanced jejunal stromal tumor: A case report of a challenging condition;International Journal of Surgery Case Reports;2024-01